KLK3 and prostate carcinoma: Seven papers [40, 41, 43–45, 47, 49] (12 indicators) reported on “early diagnosis and predisposition exams”, namely: screening visit for prostate cancer (US), gBRCA testing (Italy), human papillomavirus tests rate, low-dose computed tomography and prostate-specific antigen measurement (all from the US).